Skip to main content
ABINAC, 5 g/100 ml, collirio soluzione per cani e gatti
  • Acetylcysteine
  • Valid

Product identification

Medicine name:
ABINAC, 5 g/100 ml, collirio soluzione per cani e gatti
ABINAC, 5 g/100 ml, collirio soluzione per cani e gatti
Active substance and strength:
  • Acetylcysteine
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS01XA08
Authorisation number:
This information is not available for this product.
Product identification number:
  • 6c962d1a-42a4-41f8-95e1-06e9a7149e52
Permanent identification number:
  • 600000101046

Product details

Pharmaceutical form:
  • Eye drops, solution
Withdrawal period by route of administration:
  • Ocular use
    • Dog
    • Cat

Availability

Package description:
Manufacturing sites for batch release:
  • Vetem S.p.A.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
This information is not available for this product.
Date of authorisation status change:
Authorisation country:
  • Italy
Responsible authority:
  • MdS
Marketing authorisation holder:
  • TREBIFARMA
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."